Adjustment of dosing of antimicrobial agents for bodyweight in adults

被引：114

作者：

Falagas, Matthew E. ^{[1
,2
,3
]}

Karageorgopoulos, Drosos E. ^{[1
]}

机构：

[1] Alfa Inst Biomed Sci, Athens 15123, Greece

[2] Henry Dunant Hosp, Dept Med, Athens, Greece

[3] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA

来源：

LANCET | 2010年 / 375卷 / 9710期

关键词：

BODY-MASS; OBESITY; PREVALENCE; MANAGEMENT; INFECTIONS; GUIDELINES; SOCIETY; WEIGHT;

D O I：

10.1016/S0140-6736(09)60743-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：248 / 251

页数：4

共 30 条

[1] Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations [J].

Bartelink, Imke H. ;

Rademaker, Carin M. A. ;

Schobben, Alfred F. A. M. ;

van den Anker, John N. .

CLINICAL PHARMACOKINETICS, 2006, 45 (11) :1077-1097

[2] Vancomycin dosing in morbidly obese patients [J].

Bauer, LA ;

Black, DJ ;

Lill, JS .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) :621-625

[3] SERUM-PROTEIN BINDING AND THE ROLE OF INCREASED ALPHA-1-ACID GLYCOPROTEIN IN MODERATELY OBESE MALE-SUBJECTS [J].

BENEDEK, IH ;

BLOUIN, RA ;

MCNAMARA, PJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) :941-946

[4] Obesity prevalence from a European perspective:: a systematic review [J].

Berghoefer, Anne ;

Pischon, Tobias ;

Reinhold, Thomas ;

Apovian, Caroline M. ;

Sharma, Arya M. ;

Willich, Stefan N. .

BMC PUBLIC HEALTH, 2008, 8 (1)

[5] Pharmacokinetic considerations in obesity [J].

Blouin, RA ;

Warren, GW .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (01) :1-7

[6] 2006 national clinical pharmacy services survey: Clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology [J].

Bond, C. A. ;

Raehl, Cynthia L. .

PHARMACOTHERAPY, 2008, 28 (01) :1-13

[7] Obesity and renal hemodynamics [J].

Bosma, R. J. ;

Krikken, J. A. ;

van der Heide, J. J. Homan ;

de Jong, P. E. ;

Navis, G. J. .

OBESITY AND THE KIDNEY, 2006, 151 :184-202

[8] Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens [J].

Carpenter, CF ;

Chambers, HF .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) :994-1000

[9] Which weight for weight-based dosage regimens in obese patients? [J].

Erstad, BL .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (21) :2105-2110

[10] Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:: a systematic review of the literature [J].

Falagas, M. E. ;

Kopterides, P. .

JOURNAL OF HOSPITAL INFECTION, 2006, 64 (01) :7-15

← 1 2 3 →